« Back
Home /
Irucalantide

Irucalantide

Item no.	HY-P5536-1ea
Manufacturer	MedChem Express
CASRN	1631160-47-8
Amount	1 ea
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	99.88
Formula	C76H106N20O18S3
Citations	[1]Teufel DP, et al. Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema. J Med Chem. 2018 Apr 12;61(7):2823-2836.
Smiles	O=C(N[C@H](C(N[C@H](C(N[C@@](C(N[C@H](CN[C@H](C(N[C@H](C(N[C@H](C1=O)CC(O)=O)=O)CCC(N)=O)=O)CC2=CN=CN2)C)=O)([H])CSCC3=CC4=CC(CSC[C@H](NC([C@@H](N1)CC(C)C)=O)C(N)=O)=C3)=O)CCCCNC(N)=N)=O)CC(C=C5)=CC=C5O)[C@@](CC6)([H])N6C([C@@H](NC([C@@H](NC([C@H](CSC4)NC(C)=O)=O)CO)=O)CC7=CC=CC=C7)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Product Description	Irucalantide is kallikrein inhibitor[1].
StorageTemperature	-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Shipping	Blue Ice
MolecularWeight	1683.97
Clinical_Information	No Development Reported
Manufacturers Research_Area	others
Solubility	DMSO : 100 mg/mL (ultrasonic)
Manufacturers Target	Ser/Thr Protease
Pathway	Metabolic Enzyme/Protease
Manufacturers Product type	Peptides

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 ea

available

Request delivery time